Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies.

Autor: Rijstenberg LL; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Hansum T; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Kweldam CF; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Department of Pathology, Maasstad Hospital, Rotterdam, the Netherlands., Kümmerlin IP; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Remmers S; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van Leenders GJLH; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

Publikováno v: Histopathology [Histopathology] 2022 Jun; Vol. 80 (7), pp. 1041-1049. Date of Electronic Publication: 2022 May 04.

Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups.

Autor: van Leenders GJLH; Department of Pathology, Erasmus University Medical Centre, Rotterdam, The Netherlands. Electronic address: g.vanleenders@erasmusmc.nl., Kweldam CF; Department of Pathology, Erasmus University Medical Centre, Rotterdam, The Netherlands., Hollemans E; Department of Pathology, Erasmus University Medical Centre, Rotterdam, The Netherlands., Kümmerlin IP; Department of Pathology, Erasmus University Medical Centre, Rotterdam, The Netherlands., Nieboer D; Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands; Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands., Verhoef EI; Department of Pathology, Erasmus University Medical Centre, Rotterdam, The Netherlands., Remmers S; Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands., Incrocci L; Department of Radiotherapy, Erasmus University Medical Centre, Rotterdam, The Netherlands., Bangma CH; Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands., van der Kwast TH; Laboratory Medicine Program, University Health Network, Toronto, Canada., Roobol MJ; Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands.

Publikováno v: European urology [Eur Urol] 2020 Feb; Vol. 77 (2), pp. 191-198. Date of Electronic Publication: 2019 Aug 19.

Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore.

Autor: Verbeek JFM; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: j.f.m.verbeek@erasmusmc.nl., Bangma CH; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands., Kweldam CF; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands., van der Kwast TH; Department of Pathology, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Kümmerlin IP; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands., van Leenders GJLH; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands., Roobol MJ; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Publikováno v: Urologic oncology [Urol Oncol] 2019 Feb; Vol. 37 (2), pp. 138-144. Date of Electronic Publication: 2018 Dec 07.

Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer.

Autor: Kweldam CF; Department of Pathology, Erasmus Medical Centre, Josephine Nefkens Institute, Rotterdam, The Netherlands., Kümmerlin IP; Department of Pathology, Erasmus Medical Centre, Josephine Nefkens Institute, Rotterdam, The Netherlands., Nieboer D; Department of Public Health, Erasmus Medical Centre, Rotterdam, The Netherlands., Steyerberg EW; Department of Public Health, Erasmus Medical Centre, Rotterdam, The Netherlands., Bangma CH; Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands., Incrocci L; Department of Radiotherapy, Erasmus Medical Centre, Rotterdam, The Netherlands., van der Kwast TH; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada., Roobol MJ; Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands., van Leenders GJ; Department of Pathology, Erasmus Medical Centre, Josephine Nefkens Institute, Rotterdam, The Netherlands.

Publikováno v: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2017 Aug; Vol. 30 (8), pp. 1126-1132. Date of Electronic Publication: 2017 May 19.

Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma.

Autor: Kweldam CF; Department of Pathology, Erasmus Medical Centre Rotterdam, The Netherlands. Electronic address: c.kweldam@erasmusmc.nl., Kümmerlin IP; Department of Pathology, Erasmus Medical Centre Rotterdam, The Netherlands., Nieboer D; Department of Public Health, Erasmus Medical Centre Rotterdam, The Netherlands., Verhoef EI; Department of Pathology, Erasmus Medical Centre Rotterdam, The Netherlands., Steyerberg EW; Department of Public Health, Erasmus Medical Centre Rotterdam, The Netherlands., Incrocci L; Department of Radiotherapy, Erasmus Medical Centre Rotterdam, The Netherlands., Bangma CH; Department of Urology, Erasmus Medical Centre Rotterdam, The Netherlands., van der Kwast TH; Laboratory Medicine Program, University Health Network, Toronto, Canada., Roobol MJ; Department of Urology, Erasmus Medical Centre Rotterdam, The Netherlands., van Leenders GJ; Department of Pathology, Erasmus Medical Centre Rotterdam, The Netherlands.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2016 Oct; Vol. 66, pp. 26-33. Date of Electronic Publication: 2016 Aug 11.